CoChat

Mechanisms of aging-related proteinopathies in Caenorhabditis elegans

Open access
Kim, Dong-Kyu, Kim, Tae Ho, Lee, Seung-Jae · 2016 · Experimental & Molecular Medicine
Cited by 42

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

Aging is the most important risk factor for human neurodegenerative diseases such as Alzheimer’s and Parkinson’s diseases. Pathologically, these diseases are characterized by the deposition of specific protein aggregates in neurons and glia, representing the impairment of neuronal proteostasis. However, the mechanism by which aging affects the proteostasis system and promotes protein aggregation remains largely unknown. The short lifespan and ample genetic resources of Caenorhabditis elegans (C. elegans) have made this species a favorite model organism for aging research, and the development of proteinopathy models in this organism has helped us to understand how aging processes affect protein aggregation and neurodegeneration. Here, we review the recent literature on proteinopathies in C. elegans models and discuss the insights we have gained into the mechanisms of how aging processes are integrated into the pathogenesis of various neurodegenerative diseases. Studies on proteinopathy, abnormal protein aggregation in cells, may yield new therapies for aging and neurodegenerative diseases. Seung-Jae Lee and colleagues at Seoul National University College of Medicine in South Korea reviewed insights into proteinopathies gained using the worm Caenorhabditis elegans as a model for aging and neurodegeneration. This tiny creature has long been used to investigate biochemical mechanisms of aging that are believed to be relevant in many organisms, including ourselves. The authors discuss recent research into several specific molecular signaling pathways in the worm that may also be involved in human ageing and in age-related diseases such as Alzheimer's and Parkinson's. They conclude that studying proteinopathies in C. elegans could reveal targets for new drugs to prevent and treat neurodegenerative conditions in humans.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/emm.2016.109

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 42

Metadata

Authors
Kim, D.-K., Kim, T. H., & Lee, S.-J.
Venue
Experimental & Molecular Medicine
Published
2016-10-07
Volume
48
Issue
10
Pages
e263-e263
ISSN
  • 1226-3613 (ISSN-L)
  • 2092-6413
OpenAlex
W2529741867
Cited by
42
References
24
FWCI
1.55
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.